Zdrowie i gospodarka · 03/08/2015

FDA to Host Public Meeting on Patient-Focused Drug Development for Nontuberculous Mycobacterial Lung Infections

The FDA is hosting a public meeting to gather patient perspectives on nontuberculous mycobacterial (NTM) lung infections and to discuss the challenges of developing effective treatments, as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V).